Cargando...
Early switch to nilotinib in a case of non-optimal response to imatinib
We report a case of excellent response to nilotinib in a 22 years old man with chronic myeloid leukemia in suboptimal response to imatinib. After diagnosis he started cytoreductive therapy with cytarabine and hydroxyurea, then he begun therapy with imatinib 400 mg/day. After 3 months of treatment, h...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SEEd
2015-10-01
|
| Colección: | Clinical Management Issues |
| Materias: | |
| Acceso en línea: | https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1135 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|